New hope for rare childhood cancer: drug trial opens
NCT ID NCT06622941
First seen Feb 04, 2026 · Last updated Apr 28, 2026 · Updated 10 times
Summary
This study tests a drug called ONO-4538 in 23 people aged 1 year and older with rhabdoid tumor, a rare and aggressive cancer. Participants must have tried at least one chemotherapy that stopped working or caused side effects. The main goal is to see if the drug shrinks tumors, with additional checks on survival and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHABDOID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hokkaido University Hospital
RECRUITINGSapporo, Hokkaido, 060-8648, Japan
-
Hyogo Prefectural Kobe Children's Hospital
RECRUITINGKobe, Hyōgo, Japan
-
Nagoya University Hospital
RECRUITINGNagoya, Aichi-ken, Japan
-
National Cancer Center Hospital
RECRUITINGChuo-ku, Tokyo, Japan
-
Osaka City General Hospital
RECRUITINGOsaka, Osaka, Japan
Conditions
Explore the condition pages connected to this study.